How long does 4-HO-EPT last?

The total duration of 4-HO-EPT via oral is 3 hours to 7 hours. Onset typically occurs within 30 minutes to 1 hour. Peak effects last 1 hour to 2 hours.

4-HO-EPT — SubstanceWiki

4-HO-EPT (4-hydroxy-N-ethyl-N-propyltryptamine) is a synthetic psychedelic tryptamine belonging to the 4-hydroxy tryptamine family — the same structural class as psilocin (4-HO-DMT). Unlike the 4-AcO compounds, which are prodrugs requiring metabolic activation, 4-HO-EPT is already in the active hydroxylated form and does not require conversion prior to receptor interaction. The compound features an ethyl and a propyl group on the terminal nitrogen, distinguishing it from the simpler symmetric analogs of psilocin.

4-HO-EPT is among the less-documented members of the 4-HO tryptamine series. Community reports suggest a psychedelic experience that shares the characteristic visual and cognitive alterations of the 4-hydroxy tryptamine family, with some users describing the experience as visually rich with a particular warmth and openness at moderate doses. The ethyl-propyl substitution pattern places it between the lighter MET/MPT analogs and the heavier DiPT analogs in terms of steric bulk, and the asymmetric alkyl substitution may contribute to a distinctive subjective character.

As with most novel psychedelic tryptamines, human pharmacological data is extremely limited, and the compound's safety and effect profile is primarily characterized through community experience reports and extrapolation from better-studied analogs. Active doses are typically in the 10–30 mg range, with duration of approximately 4–6 hours.

How It Feels

The onset of 4-HO-EPT is gentle and unassuming. Thirty to forty-five minutes after ingestion, a soft warmth begins to build in the body, accompanied by a mild tingling in the scalp and fingertips. There is little to no nausea, and the transition from baseline feels more like a gradual turning of a dial than a threshold crossing. Colors become slightly more vivid, edges soften almost imperceptibly, and there is a quiet sense of heightened presence — the world does not look radically different, but it seems somehow more worthy of attention.

Over the next hour, the visual effects develop to a gentle plateau. Surfaces may show a subtle breathing quality — slow, rhythmic expansions and contractions that are easy to miss unless one is looking for them. Textures become more interesting: the grain of wood, the weave of fabric, the patterns in clouds all seem to reveal detail that was previously overlooked. Colors warm slightly, taking on a soft, golden quality. Closed-eye visuals are modest but pleasant: slow-moving fields of pastel color, simple geometric forms that drift and rotate lazily, and occasional fleeting imagery that dissolves before it fully resolves.

The peak, arriving around ninety minutes and lasting one to two hours, is characterized by its mildness and accessibility. The headspace is light and clear — thoughts flow easily, conversation is natural, and there is no sense of cognitive impairment or disorientation. A gentle mood lift pervades the experience, a quiet contentment that makes simple activities feel rewarding. Music is subtly enhanced, with slightly increased emotional resonance and spatial depth. The body feels comfortable and relaxed, pleasantly heavy without being sedated. This is not a substance that overwhelms or challenges; it is more akin to a gentle widening of the aperture of perception.

The comedown is smooth and almost imperceptible, the mild enhancement gradually fading over one to two hours until baseline is reached. The total duration is typically three to five hours. There is a brief, subtle afterglow of quiet wellbeing, and sleep comes easily afterward. The overall experience of 4-HO-EPT is that of a psychedelic whisper — faint, gentle, and easily overlooked, but carrying a genuine softness that can be appreciated for its own understated character.

Detection Methods

Urine Detection

4-HO-EPT is not targeted by standard immunoassay-based urine drug screens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.

Blood and Serum Detection

Blood detection windows for 4-HO-EPT are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.

Standard Drug Panel Inclusion

4-HO-EPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.

Confirmatory Methods

Confirmatory identification of 4-HO-EPT relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.

Reagent Testing (Harm Reduction)

The Ehrlich reagent is the primary harm reduction tool for 4-HO-EPT. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Acute Toxicity

No formal toxicological data in humans. Safety profile is inferred from class membership (4-hydroxy tryptamines, which include the extensively studied psilocin) and community-accumulated experience. The class as a whole demonstrates very low acute physiological toxicity.

Physiological Effects

Mild to moderate sympathomimetic effects characteristic of the tryptamine class: pupil dilation, moderate tachycardia, possible nausea during onset. The longer alkyl chains may increase the likelihood of a physical "body load" — somatic heaviness, tension, or temperature dysregulation — relative to simpler analogs such as 4-HO-DMT or 4-HO-MET.

Psychological Risks

Anxiety and panic — Risk increases with dose, unfamiliar settings, and psychological unpreparedness.
Psychosis induction — Contraindicated for those with personal or family history of schizophrenia or psychotic disorders.
HPPD — Rare but possible, as with all 5-HT2A agonist psychedelics.

Drug Interactions

MAOIs — Potentiation; serotonin syndrome risk; avoid.
Lithium — Seizure risk; absolute contraindication.
Cannabis — Significant unpredictable amplification.
SSRIs/SNRIs — May reduce effects; abrupt discontinuation of antidepressants for this purpose carries serious risks.

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 4-HO-EPT alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

4-HO-EPT

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(5)

Cognitive & Perceptual Effects

Visual(16)

Pharmacology

5-HT2A Partial Agonism

Additional Receptor Interactions

Pharmacokinetics

Tolerance

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Origins

Research Chemical Context

Harm Reduction

Verification

Dosing

Prepare Thoughtfully

Avoid Dangerous Combinations

Toxicity & Safety

Acute Toxicity

Physiological Effects

Psychological Risks

Drug Interactions

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (4)

See Also

References (4)

Frequently Asked Questions

Cognitive(10)

Transpersonal(2)